Sosei Heptares and Verily Nominate First G-protein-coupled r

Nomination of novel drug target based on insights generated through application of Verily’s Immune Profiler platform and Sosei Heptares’ GPCR-focused structure-based drug design expertise

...

Related Keywords

Japan , United Kingdom , London , City Of , Tokyo , Seoul , Soult Ukpyolsi , South Korea , Sosei Heptares , Charlie Kim , Sosei Heptare , Matt Barnes , Sosei Group , Tokyo Stock Exchange , European Federation Of Crohn Ulcerative Colitis Associations , Sosei Group Corporation , Twitter , Sosei Group Corporation Heptares , Research Use , Youtube , Linkedin , Heptares Therapeutics , Immune Profiler , Molecular Science , European Federation , Ulcerative Colitis Associations , Group Corporation , Markets ,